Ganglioside GD2 in Serum (Quantitative)

GD2 is a molecule called a disialoganglioside that sits on the surface of certain cells, including some cancer cells such as neuroblastoma and melanoma cells. Measuring GD2 in the body can help doctors evaluate these conditions and make informed decisions about your care.

GD2 is a complex carbohydrate molecule (ganglioside) that plays a role in cell signaling and is particularly abundant in certain types of nerve tissues and some cancers. It can be detected in blood serum through specialized laboratory techniques.

Your doctor may order a GD2 test if they suspect a tumor that produces this marker, such as neuroblastoma or melanoma, or to monitor a known cancer over time. It can help show how well treatment is working, check whether the disease has returned, or provide additional information alongside other tests.

Your healthcare provider may recommend this test if you have symptoms or a history suggestive of conditions like neuroblastoma (a childhood cancer of nerve cells), certain brain tumors, or other neurological disorders. It may also be used in research or specialized diagnostic contexts.

This test is usually performed on a small blood sample drawn from a vein in your arm by a trained health professional. No fasting or special preparation is typically required, but tell your care team about any medications or supplements you take and follow any specific instructions they give you before your appointment.

A blood sample is drawn from a vein, typically in the arm. The blood is processed to separate serum (the liquid part without clotting factors), which is then analyzed for GD2 levels. This process helps ensure accurate measurement of the analyte.

In the laboratory, your blood sample is analyzed using specialized methods that detect and measure the amount of GD2 present. The result is compared with established reference ranges, and your doctor interprets the value together with your symptoms, medical history, imaging, and other laboratory findings.

The test uses a specialized technique, such as **line blot immunoassay**, to detect and quantify GD2 in the serum. This method relies on antibodies that bind specifically to GD2, allowing precise measurement of its concentration.